MCO-010 achieved its primary and key secondary endpoints with statistical significance and no serious adverse events Data from the Phase 2b RESTORE trial demonstrate clinically meaningful vision improvement in legally …
Health
-
Uncategorized
-
Uncategorized
Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB
by PRNW Agencyby PRNW AgencyAUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures CANBERRA, Australia, March 24, 2024 /PRNewswire/ — The Australian Government, through the Partnerships for a Healthy Region initiative, …
-
Uncategorized
FDI World Dental Federation releases powerful video message unifying voices in celebration of World Oral Health Day
by PRNW Agencyby PRNW AgencyIn celebration of World Oral Health Day, FDI World Dental Federation debuts an impactful video message uniting voices from diverse sectors, advocating for collective efforts to improve oral health worldwide. …
-
Uncategorized
Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate
by PRNW Agencyby PRNW AgencyA large Phase 3 trial will evaluate whether the M72/AS01E vaccine candidate can protect adolescents and adults from pulmonary tuberculosisClinical trial site at University of the Witwatersrand, Johannesburg, South Africa, …
-
Uncategorized
Fapon Empowers Indian IVD Manufacturers at Medical Fair India 2024
by PRNW Agencyby PRNW AgencyDONGGUAN, China, March 14, 2024 /PRNewswire/ — Fapon, a global leading life sciences company, continues its commitment in empowering the Indian IVD industry at Medical Fair India 2024, which is held …
-
Uncategorized
Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma
by PRNW Agencyby PRNW AgencyThe independent data monitoring committee (IDMC) has recommended continuation of CLINGLIO without modification after its assessment of LAM561 interim efficacy in newly diagnosed Glioblastoma. This follows the previous recommendation in …
-
Uncategorized
Optimum Nutrition Launches New Global Marketing Campaign “Unlock More You”
by PRNW Agencyby PRNW AgencyThe campaign taps into the universal human desire to unlock more within ourselves, regardless of athletic ability or achievement DUBLIN, March 4, 2024 /PRNewswire/ — Optimum Nutrition, the world’s #1 …
-
Uncategorized
Curadev Announces First Treatment Cycle Completion for the First Patient Dosed in a Phase 1a/b Clinical Trial of its Allosteric STING Agonist CRD3874-SI in Patients with Advanced Cancer at Memorial Sloan Kettering Cancer Center in New York
by PRNW Agencyby PRNW AgencyCRD3874-SI is a small molecule drug designed to target the STimulator of INterferon Genes, to activate immune cells to identify and eradicate tumors BOSTON and NOIDA, India, Feb. 27, 2024 …
-
Uncategorized
Takeda Accelerates Access to its Dengue Vaccine Through ‘Make in India’ Manufacturing Partnership with Biological E.
by PRNW Agencyby PRNW AgencyNew strategic partnership will scale-up manufacturing capacity to support global supply of dengue vaccine and expands Takeda’s footprint in vaccine manufacturing.The strategic partnership will deliver potentially up to 50 million doses …
-
Uncategorized
UFC WORLD CHAMPION JON JONES, LIFECYKEL LABS, CANTERBURY-BANKSTOWN BULLDOGS AND BETTER BREATHING DEVICES HOST ELITE PERFORMANCE/TRAINING DAY
by PRNW Agencyby PRNW AgencySYDNEY, Feb. 9, 2024 /PRNewswire/ — Jon Jones, UFC world champion and arguably the best MMA fighter to have ever existed is touring Australia and has teamed up with Lifecykel Labs …